Squamous Cell Carcinoma of the Oropharynx Clinical Trial
Official title:
Comparative Study of Hypoxia Measured in F-Miso PET/Scan and MRI in Patients With Squamous Cells Carcinoma : Correlation With Immunohistochemistry
Hypoxia imaging has not been studied extensively by combining PET and MRI data. Few studies performed the double imaging and none associated anatomopathology with it . This study will use a rigorous methodology through the production of PET/MRI images at the same time by transferring the patient directly from PET to MRI. In addition, the population, unlike other studies, will include preoperative patients with 24-hour surgery for hypoxia imaging by obtaining additional data through specific immunohistochemical analysis of hypoxia.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05540899 -
Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT03669718 -
A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC
|
Phase 2 | |
| Withdrawn |
NCT01586182 -
Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04151134 -
Evaluation of Tongue Base MucOsectomy & Step sErial Sectioning
|
||
| Not yet recruiting |
NCT06380686 -
Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome
|
||
| Recruiting |
NCT05119036 -
Adjuvant Treatment Deintensification After Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma
|
Phase 2 | |
| Not yet recruiting |
NCT05608369 -
Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC
|
Phase 2 | |
| Terminated |
NCT02552550 -
Swallowing, Speech and Quality of Life of Patients With Carcinoma of the Oropharynx
|
||
| Active, not recruiting |
NCT04398524 -
A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC
|
Phase 2 | |
| Recruiting |
NCT06030440 -
De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck
|
Phase 2/Phase 3 | |
| Completed |
NCT01663259 -
Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients
|
N/A | |
| Recruiting |
NCT04104945 -
p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT)
|
N/A | |
| Not yet recruiting |
NCT05962242 -
HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma
|
Phase 2 | |
| Not yet recruiting |
NCT06061705 -
Identification of Individual Histological and Blood Markers in Patients With Recurrent or Metastatic Upper Aerodigestive Tract Squamous Cell Carcinoma in Response to Immunotherapies
|
N/A | |
| Active, not recruiting |
NCT03370276 -
Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06112535 -
Prospective Clinical Study to Assess the Safety and Efficacy of Versius, in Transoral Robotic Surgery
|
N/A | |
| Completed |
NCT01921426 -
A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck
|
Phase 1 | |
| Completed |
NCT01181648 -
Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life
|
||
| Recruiting |
NCT05918510 -
Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus
|
||
| Recruiting |
NCT05894083 -
A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)
|
Phase 2 |